IDev takes thrombectomy device to the US:
This article was originally published in Clinica
Executive Summary
The FDA has given IDev Technologies the go-ahead to market in the US its AKonya Eliminator thrombectomy device as a tool for declotting synthetic dialysis grafts. The device's high radial force and vessel wall compliance allow for removal of adherent clot or highly calcified lesions in various dialysis graft sizes, says the Houston, Texas firm. Axial and rotational manipulation of the product's Thrombasket, a woven mesh structure, serves as the mechanism of action for thrombus maceration. The device is already available in Europe.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.